Gene clue to Kids' stomach bugs revealed
NCT ID NCT07289451
First seen Jun 27, 2026 ยท Last updated Jun 27, 2026
Summary
This study looked at whether a specific gene (TLR9) influences how children's bodies react to H. pylori, a bacteria that can cause stomach pain and inflammation. Researchers compared 50 infected children with 50 uninfected children, all aged 1 to 18, using endoscopy and genetic testing. The goal was to understand the gene's role in infection and gastritis, not to test a new treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
100 people
The number who actually took part.
- Started
-
Jan 2023
- Finished
-
Sep 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
1 year to 18 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. children with age between 1 and 18 years with gastrointestinal symptoms that necessitates upper digestive endoscopy like: * persistent pain in the abdomen and/or the stomach, * Heartburn, * vomiting, * nausea. 2. children who showed red flag signs like : * anemia, * gastrointestinal hemorrhage, * failure to thrive, * increased ESR . Exclusion Criteria: * cases on proton pump inhibitors, * those with substantial medical diseases, * those with gastrointestinal conditions that could explain their stomach discomfort (such as celiac disease, functional abdominal pain and inflammatory bowel disease).
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for H.pylori infection are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Faculty of Medicine Benha University
Cairo, Egypt
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New Two-Drug combo shows promise against stomach bug
- Which test is better for detecting h. pylori?
- New stomach bug treatment shows promise in 14-Day trial
- Stomach bug treatment may lower bleeding risk for heart patients
- Scientists map h. Pylori's resistance to antibiotics
- Argon plasma zaps stomach bugs in new trial